6.82
-0.23(-3.26%)
Currency In USD
| Previous Close | 7.05 |
| Open | 7.07 |
| Day High | 7.07 |
| Day Low | 6.81 |
| 52-Week High | 28 |
| 52-Week Low | 5.25 |
| Volume | 151,502 |
| Average Volume | 486,378 |
| Market Cap | 278.61M |
| PE | -4.43 |
| EPS | -1.54 |
| Moving Average 50 Days | 7.14 |
| Moving Average 200 Days | 10.11 |
| Change | -0.23 |
If you invested $1000 in Senseonics Holdings, Inc. (SENS) 10 years ago, it would be worth $104.92 as of December 14, 2025 at a share price of $6.82. Whereas If you bought $1000 worth of Senseonics Holdings, Inc. (SENS) shares 5 years ago, it would be worth $811.9 as of December 14, 2025 at a share price of $6.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
GlobeNewswire Inc.
Nov 10, 2025 1:05 PM GMT
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for
Senseonics Announces Transfer to Nasdaq Stock Exchange
GlobeNewswire Inc.
Nov 10, 2025 1:00 PM GMT
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for p
Senseonics Holdings, Inc. Reports Third Quarter Financial Results
GlobeNewswire Inc.
Nov 05, 2025 9:05 PM GMT
Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Sense